Global Angiography Equipment Market Size By Technology, By Procedure, By Application, By Geographic Scope And Forecast

Angiography Equipment Market Size And Forecast

Angiography Equipment Market size was valued at USD 13.48 Billion in 2023 and is projected to reach USD 19.18 Billion by 2031, growing at a CAGR of 4.97% from 2024 to 2031.

Angiography equipment is an important tool in modern diagnostic imaging as it allows doctors to see inside blood arteries and organs to diagnose and monitor a variety of medical disorders. This device uses imaging methods such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) to create detailed images of blood arteries, the heart, and other internal structures.

It is essential in the medical industry as it is used to image and diagnose a variety of vascular disorders. The major application of angiography technology is to visualize blood arteries and organs. This imaging approach is critical for detecting and treating cardiovascular ailments such as coronary artery disease (CAD), aneurysms, and peripheral artery disease (PAD).

The use of angiography equipment in the future is expected to grow significantly as a result of technical advances and changing healthcare needs. One of the most noticeable trends is the incorporation of modern imaging technologies like 3D imaging and hybrid modalities. The development of high-resolution 3D angiography devices allows for more detailed and accurate viewing of blood arteries and related structures which improves diagnostic precision and aids in better planning of interventional operations.

Global Angiography Equipment Market Dynamics

The key market dynamics that are shaping the global angiography equipment market include:

Key Market Drivers:

Technological Advancements: Technological innovation is a key driver of the angiography equipment industry. Recent improvements have resulted in the creation of more advanced angiography systems such as those with high-definition imaging, improved contrast resolution, and real-time 3D imaging capabilities. DSA and hybrid imaging systems which integrate angiography with CT or MRI, are examples of innovations that have increased diagnostic accuracy and procedure efficiency.

Increasing Prevalence of Cardiovascular Diseases: The increased prevalence of cardiovascular diseases (CVDs) is a significant driver of the angiography equipment industry. CVDs such as coronary artery disease, stroke, and peripheral artery disease are major causes of morbidity and mortality globally. The World Health Organization (WHO) estimates that cardiovascular illnesses cause roughly 17.9 million deaths each year, accounting for 32% of all global deaths.

Rising Geriatric Population: The growing geriatric population is another important driver of the angiography equipment industry. Individuals' susceptibility to cardiovascular illnesses and other health disorders that necessitate angiography increases with age. According to the United Nations, the global population aged 60 and over is expected to reach 2.1 billion by 2050, up from 1 billion in 2020. This demographic trend is driving up demand for angiography operations and, by extension, angiography equipment.

Key Challenges:

Rising Geriatric Population: The growing geriatric population is another important driver of the angiography equipment industry. Individuals' susceptibility to cardiovascular illnesses and other health disorders that necessitate angiography increases with age. According to the United Nations, the global population aged 60 and over is expected to reach 2.1 billion by 2050 up from 1 billion in 2020. This demographic trend is driving up demand for angiography operations and, by extension, angiography equipment.

Technological Complexity and Training Needs: The advanced nature of current angiography technology complicates operation and maintenance. High-end systems frequently use advanced imaging technologies such as 3D imaging and real-time image processing which require specialized knowledge and abilities to function well. Because of the technological complexity, medical practitioners, especially radiologists and technicians must receive substantial training to ensure accurate imaging and proper equipment use.

Regulatory Compliance and Safety Concerns: Angiography equipment must adhere to severe regulatory requirements and safety norms which might differ dramatically among areas. To comply with these rules, producers must invest in extensive testing, certification, and quality assurance methods. Furthermore, the use of contrast agents in angiography has significant safety hazards including as allergic responses and nephrotoxicity which must be carefully managed and monitored.

Key Trends:

Advancements in Imaging Technology: Rapid advancements in imaging technology are one of the most important developments in the angiography equipment market. Modern angiography systems use cutting-edge technologies including 3D imaging, high-resolution detectors, and advanced contrast imaging. These advancements allow for more exact and detailed viewing of blood arteries which is critical for effective diagnosis and treatment planning.

Growing Prevalence of Cardiovascular Diseases: The rising frequency of cardiovascular disorders is a significant driver of growth in the angiography equipment market. Cardiovascular disease which includes coronary artery disease, stroke, and peripheral artery disease is one of the main causes of death worldwide. According to the World Health Organization (WHO), cardiovascular illnesses account for around 32% of global deaths.

Emergence of Minimally Invasive Techniques: Minimally invasive techniques are becoming more common in angiography treatments driven by patient preferences for shorter recovery times and fewer problems. Modern angiography systems are intended to accommodate these methods which require the use of catheters and other equipment put through small incisions. This method lowers the need for extensive surgical incisions resulting in faster patient recovery and reduced postoperative pain.

Global Angiography Equipment Market Regional Analysis

Here is a more detailed regional analysis of the global angiography equipment market:

North America:

North America emerged as the market's dominant region with a considerable 33.1% share. Several major variables are expected to contribute to this leading position's continued strength. One of the key factors contributing to North America's market dominance is the region's expanding elderly population which has a substantial impact on demand for medical equipment and healthcare services. Individuals become more vulnerable to chronic disorders like cardiovascular diseases (CVDs) as they age necessitating the use of modern medical procedures and monitoring systems. The prevalence of CVDs in North America is particularly high increasing the demand for medical devices developed to manage and treat these diseases.

Furthermore, the region's well-established healthcare infrastructure as well as the presence of large corporations and industry leaders in the United States, contribute significantly to the region's market share retention. These companies not only advance technological advancements but also drive growth through significant investments in R&D. This strong industry presence assures that North America remains at the forefront of the market capitalizing on sophisticated medical technology and comprehensive healthcare services to meet the needs of its aging population.

Asia Pacific:

Asia Pacific is expected to be the fastest-growing region in the global market with a compound annual growth rate (CAGR) of 6.2% during the forecast period. This growth trajectory is largely due to several positive elements that are increasing the region's appeal to investors and enterprises. One of the primary reasons is the availability of supporting reimbursement policies in many nations in the region which encourage technological improvements and the use of cutting-edge equipment.

In addition, certain Asia Pacific countries, like South Korea, India, and Brazil, have a more lenient regulatory environment than other areas. This less stringent regulatory environment creates a substantial opportunity for multinational corporations looking to grow their presence in these new regions. The loosened regulatory frameworks enable faster market entrance and easier approval processes for new products and technologies. For example, India's regulatory authority, the Central Drugs Standard Control Organization (CDSCO) has simplified its medical device approval processes making it easier for companies to deliver new products to the Indian market.

Global Angiography Equipment Market: Segmentation Analysis

The Global Angiography Equipment Market is segmented based on Technology, Procedure, Application, and Geography.

Angiography Equipment Market, By Technology

• X-Ray Angiography
• CT Angiography
• MR Angiography

Based on the Technology, the Global Angiography Equipment Market is bifurcated into X-Ray Angiography, CT Angiography, and MR Angiography. In the global angiography equipment market, X-ray angiography is the dominant technology. This dominance is primarily due to its long-established use, high image resolution, and effectiveness in diagnosing and treating a wide range of vascular conditions. X-ray angiography is widely adopted because it provides detailed real-time imaging which is crucial for accurate diagnosis and intervention in procedures like coronary angioplasty and stent placement.

Angiography Equipment Market, By Procedure

• Coronary Angiography
• Endovascular Angiography
• Neuro Angiography

Based on the Procedure, the Global Angiography Equipment Market is bifurcated into Coronary Angiography, Endovascular Angiography, and Neuro Angiography. In the global angiography equipment market, coronary angiography is the dominant procedure segment. This dominance is primarily due to the high prevalence of cardiovascular diseases worldwide including coronary artery disease and heart attacks which drives substantial demand for coronary angiography procedures. Coronary angiography is crucial for diagnosing and evaluating coronary artery conditions guiding treatment strategies, and planning interventions such as stenting or bypass surgery.

Angiography Equipment Market, By Application

• Diagnostic Angiography
• Therapeutic Angiography

Based on the Application, the Global Angiography Equipment Market is bifurcated into Diagnostic Angiography and Therapeutic Angiography. In the global angiography equipment market, Diagnostic Angiography is the dominant segment. This dominance is driven by the widespread use of diagnostic angiography in identifying and assessing various cardiovascular and vascular conditions such as coronary artery disease, aneurysms, and stroke. Diagnostic angiography is crucial for early disease detection and treatment planning which increases its demand across hospitals and diagnostic centers.

Key Players

The "Global Angiography Equipment Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corporation, Boston Scientific Corporation, and Cordis Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Angiography Equipment Market Key Developments

• In August 2023, Canon Medical, a medical equipment firm, will sell its Alphenix/Evolve Edition angiography system in the European market. The device uses real-time deep learning technology to improve imaging and reduce radiation dose during percutaneous coronary intervention and structural heart disease operations.
• In April 2023, Caristo Diagnostics Limited, a global leader in cardiac and vascular disease diagnostics and risk assessment, completed its Series a financing round with an additional USD 16.3 million raised. Caristo plans to use the funds to develop its CaRi-Heart technology, a risk prediction tool, and Al-assisted diagnostics, to make it the standard for cardiac care in key international markets. CaRi-Heart's AI algorithms, which use Caristo's Fat Attenuation Index (FAI) technology, allow experienced medical practitioners to obtain coronary inflammatory values from standard Cardiac Computed Tomography Angiography (CCTA).